Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease

Trial Phase 4 Terminated Dec. 19, 2010

REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study

Trial Phase 4 Completed Dec. 14, 2010

Biofeedback to Ameliorate Freezing of Gait

Trial N/A Unknown Dec. 13, 2010

Sensory Attention Focused Exercise in Parkinson's Disease

Trial N/A Unknown Nov. 22, 2010

Reduction of Falls in the Elderly - Parkinson's Disease

Trial Phase 3 Completed Nov. 22, 2010

Visual Selective Attention in Parkinson's Disease

Trial N/A Completed Nov. 21, 2010

Enteric Nervous System in Parkinson's Disease

Trial N/A Completed Nov. 15, 2010

Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease

Trial Phase 4 Terminated Nov. 10, 2010

Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease

Trial N/A Unknown Nov. 10, 2010

Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial

Trial Phase 3 Completed Nov. 4, 2010

Biofeedback-based Motor Learning to Ameliorate Freezing of Gait

Trial N/A Unknown Oct. 18, 2010

A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

Trial N/A Completed Oct. 17, 2010

Pilot Study of Maintenance Therapy With Intravenous AMANTADINE

Trial N/A Unknown Oct. 12, 2010

Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects and Parkinson Disease Patients

Trial Phase 1 Terminated Oct. 5, 2010

Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611

Trial Phase 1 Completed Oct. 4, 2010

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

Trial Phase 2 Completed Sept. 28, 2010

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

Trial Phase 3 Completed Sept. 12, 2010

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

Trial Phase 4 Completed Sept. 7, 2010

Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease

Trial Phase 3 Completed Aug. 23, 2010

Levodopa Concentration Profile With Stalevo 75/125 mg

Trial Phase 1 Completed Aug. 12, 2010